What 7 Analyst Ratings Have To Say About Guardant Health
Portfolio Pulse from Benzinga Insights
Guardant Health (NASDAQ:GH) has received 7 analyst ratings in the last quarter, with 3 bullish and 4 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for GH is $41.57, with a high of $50.00 and a low of $27.00. This average has decreased by 20.44% from the previous average price target of $52.25. Analysts rate stocks based on research and provide guidance to investors, though their ratings are opinions and subject to human error.
December 13, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guardant Health has received a majority of positive ratings from analysts, with an average price target of $41.57, which is a decrease from the previous target of $52.25.
The predominance of bullish ratings suggests a positive sentiment among analysts, which could influence investor perception and potentially lead to a short-term increase in GH's stock price. However, the decrease in the average price target may temper expectations and could indicate a more cautious outlook on the company's valuation.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100